脊椎生物製剤の世界市場レポート 2025年

脊椎生物製剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.3％で30億6,000万米ドルに成長します。予測期間の成長は、技術革新、再生医療導入の増加、研究開発投資の増加、肥満と座りがちなライフスタイルの蔓延、新興市場におけるヘルスケアアクセスの拡大、有利な規制承認、業界内での提携やパートナーシップの増加などに起因すると考えられます。予測期間における主な動向としては、新規再生療法の出現、治療計画における人工知能の統合、個別化医療アプローチの拡大、カスタマイズインプラントへの3Dプリンティングの採用、組織再生強化のための生体工学的足場の開発などが挙げられます。

交通事故の発生率の増加は、脊椎生物学的製剤市場の成長を当面牽引するとみられます。交通事故とは、公道上で1台以上の車両が関与する意図しない出来事で、重度の脊髄損傷をもたらすものと定義され、効果的な治療と回復のために高度な医療介入が必要となります。世界的に交通事故は、脇見運転、交通量の増加、不十分な道路インフラ、アルコールや薬物による障害など、さまざまな要因により増加傾向にあります。脊椎生物学的製剤は、脊椎固定の促進、治癒の促進、手術リスクの軽減、疼痛管理の改善、再手術の必要性の最小化により、患者の転帰を向上させる上で重要な役割を果たしています。例えば、米国高速道路交通安全局のデータによると、米国だけでも昨年、推定4万2,915人が自動車交通事故で命を落としており、2020年に記録された死亡者数3万8,824人から10.5％増加しています。したがって、交通事故件数の増加が脊椎生物学的製剤市場の拡大に拍車をかけています。

脊椎生物学的製剤市場の主要企業は、患者のニーズによりよく対応し、市場での競合優位性を維持するため、合成生体活性骨移植片などの先進製品の開発に注力しています。合成生体活性骨移植片は、脊椎固定術における骨の成長と治癒をサポートし強化するために人工的に設計された脊椎生物製剤です。例えば、米国の脊椎・整形外科企業であるOrthofix Medical Inc.は、2022年2月にOpus BAを発表しました。オーパスBAはパテ状とストリップ状があり、骨成長の足場として機能し、再吸収されて天然骨に置き換わる。オーパスBAは、自家骨髄または生理食塩水による自家移植が可能で、炭酸アパタイト骨ミネラル、生物活性ガラス、1型コラーゲンからなる骨伝導性マトリックスを特徴としており、骨の成長と吸収を促進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界脊椎生物製剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の脊椎生物製剤市場：成長率分析
• 世界の脊椎生物製剤市場の実績：規模と成長, 2019-2024
• 世界の脊椎生物製剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界脊椎生物製剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の脊椎生物製剤市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨同種移植
• 骨移植代替品
• 多血小板血漿
• 骨髄穿刺療法
• 世界の脊椎生物製剤市場手術の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 頸椎前方椎間板切除術および固定術（ACDF）
• 後方腰椎椎体間固定術（PLIF）
• 経椎間孔腰椎椎体間固定術（TLIF）
• 前方腰椎椎体間固定術（ALIF）
• 側方腰椎椎体間固定術（LLIF）
• その他の手術の種類
• 世界の脊椎生物製剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脊椎固定術
• 脊椎癒合不全および骨折の修復
• 変性椎間板疾患の治療
• その他の用途
• 世界の脊椎生物製剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 脊椎手術センター
• 整形外科クリニック
• その他のエンドユーザー
• 世界の脊椎生物製剤市場骨移植の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 新鮮同種移植
• 凍結乾燥同種移植
• 世界の脊椎生物製剤市場骨移植代替品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成骨移植
• 脱灰骨基質（DBM）
• リン酸カルシウム系移植
• 多血小板血漿（PRP）
• 世界の脊椎生物製剤市場骨髄穿刺療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 濃縮骨髄穿刺液
• 骨髄濃縮物

第7章 地域別・国別分析

• 世界の脊椎生物製剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の脊椎生物製剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脊椎生物製剤市場：競合情勢
• 脊椎生物製剤市場：企業プロファイル
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Zimmer Biomet Holdings Inc.
• Arthrex Inc.
• Integra LifeSciences Corporation
• Bone Biologics Corp.
• InVivo Therapeutics Corp.
• RTI Surgical Inc.
• Paragon 28 Inc.
• LifeNet Health Inc.
• Xtant Medical Holdings Inc.
• Kuros Biosciences A.G.
• CoreLink LLC
• Spinal Elements Inc.
• Life Spine Inc.
• Innovasis Inc.
• Camber Spine Technologies LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 脊椎生物製剤市場2029：新たな機会を提供する国
• 脊椎生物製剤市場2029：新たな機会を提供するセグメント
• 脊椎生物製剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Spine biologics, also referred to as spinal biologics, encompass biologically derived materials employed in the treatment of spinal conditions and injuries. These materials are utilized to stimulate bone formation, accelerate healing, and enhance the outcomes of spine surgery, particularly spinal fusion procedures. They encompass a variety of products, including bone grafts, growth factors, cell-based therapies, and biological scaffolds.

The primary products within spine biologics include bone allografts, bone graft substitutes, platelet-rich plasma, and bone marrow aspirate therapy. Bone allografts are grafts sourced from donors rather than from the patient's own body. Spine biologics find application across various types of surgeries, including anterior cervical discectomy and fusion (ACDF), posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and others. These products are utilized for diverse applications such as spinal fusion, treatment of spinal non-union and fractures, management of degenerative disc disease, among others. They are employed by various end users including hospitals, spinal surgery centers, orthopedic clinics, and others.

The spine biologics market research report is one of a series of new reports from The Business Research Company that provides spine biologics market statistics, including spine biologics industry global market size, regional shares, competitors with a spine biologics market share, detailed spine biologics market segments, market trends and opportunities, and any further data you may need to thrive in the spine biologics industry. This spine biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spine biologics market size has grown strongly in recent years. It will grow from $2.36 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to advancements in biotechnology, an aging population, a high incidence of spinal disorders, increased preference for minimally invasive procedures, high awareness about spine health, improvements in diagnostic techniques, and enhanced healthcare infrastructure.

The spine biologics market size is expected to see strong growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to technological innovations, increasing adoption of regenerative medicine, rising investment in R&D, growing prevalence of obesity and sedentary lifestyles, expanding healthcare access in emerging markets, favorable regulatory approvals, and increasing collaborations and partnerships within the industry. Major trends in the forecast period include emergence of novel regenerative therapies, integration of artificial intelligence in treatment planning, expansion of personalized medicine approaches, adoption of 3D printing for customized implants, and development of bioengineered scaffolds for enhanced tissue regeneration.

The increasing incidence of road accidents is poised to drive the growth of the spinal biologics market in the foreseeable future. Road accidents, defined as unintended events involving one or more vehicles on public roads resulting in severe spinal injuries, necessitate advanced medical interventions for effective treatment and recovery. Globally, road accidents are on the rise due to various factors, including distracted driving, higher traffic volumes, inadequate road infrastructure, and impairment from alcohol and drugs. Spinal biologics play a crucial role in enhancing patient outcomes by promoting spinal fusion, accelerating healing, reducing surgical risks, improving pain management, and minimizing the need for revision operations. For example, data from the National Highway Traffic Safety Administration reveals that in the US alone, an estimated 42,915 individuals lost their lives in motor vehicle traffic crashes last year, representing a 10.5% increase from the 38,824 fatalities recorded in 2020. Hence, the escalating number of road accidents is fueling the expansion of the spinal biologics market.

Leading companies in the spinal biologics market are focusing on developing advanced products, such as synthetic bioactive bone grafts, to better cater to patient needs and maintain a competitive edge in the market. Synthetic bioactive bone grafts are artificial spine biologics engineered to support and enhance bone growth and healing in spinal fusion surgeries. For instance, Orthofix Medical Inc., a US-based spine and orthopedics company, introduced Opus BA in February 2022. Opus BA, available in putty and strip forms, serves as a scaffold for bone growth, which is reabsorbed and replaced by natural bone. It can be hydrated with autogenous bone marrow or autografted with saline and features an osteoconductive matrix comprising carbonate apatite bone mineral, bioactive glass, and Type 1 collagen, facilitating bone growth and resorption.

In August 2023, Xtant Medical, a US-based medical technology company, acquired specific assets and liabilities of domestic and international biologics and spinal fixation products from Surgalign Holdings Inc. for an undisclosed sum. This strategic acquisition is poised to bolster Xtant Medical's product portfolio and market presence in the orthopedic and spine surgery sectors, leveraging the combined capabilities of both entities. Surgalign Holdings Inc. is a US-based medical technology company specializing in spine biologics and spinal fixation products.

Major companies operating in the spine biologics market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Arthrex Inc., Integra LifeSciences Corporation, Bone Biologics Corp., InVivo Therapeutics Corp., RTI Surgical Inc., Paragon 28 Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., CoreLink LLC, Spinal Elements Inc., Life Spine Inc., Innovasis Inc., Camber Spine Technologies LLC, SurGenTec LLC, ChoiceSpine LLC, Cerapedics Inc, Aziyo Biologics, Amedica Corporation

North America was the largest region in the spine biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spine biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spine biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The spine biologics market consists of sales of bone morphogenetic proteins, synthetic bone grafts, and spine fusion systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spine Biologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spine biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spine biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spine biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Bone Allografts; Bone Graft Substitute; Platelet Rich Plasma; Bone Marrow Aspirate Therapy
• 2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF); Posterior Lumbar Interbody Fusion (PLIF); Transforaminal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF); Other Surgery Types
• 3) By Application: Spinal Fusion; Spinal Non-Union And Fracture Repair; Degenerative Disc Disease Treatment; Other Applications
• 4) By End User: Hospitals; Spinal Surgery Centers; Orthopedic Clinics; Other End Users
• Subsegments:
• 1) By Bone Allografts: Fresh Allografts; Freeze-Dried Allografts
• 2) By Bone Graft Substitute: Synthetic Bone Grafts; Demineralized Bone Matrix (DBM); Calcium Phosphate-Based Grafts; Platelet Rich Plasma (PRP)
• 3) By Bone Marrow Aspirate Therapy: Concentrated Bone Marrow Aspirate; Bone Marrow Concentrates
• Companies Mentioned: Johnson & Johnson Services Inc.; Medtronic PLC; Stryker Corporation; Baxter International Inc.; B. Braun Melsungen AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Spine Biologics Market Characteristics

3. Spine Biologics Market Trends And Strategies

4. Spine Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Spine Biologics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Spine Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Spine Biologics Market Growth Rate Analysis
• 5.4. Global Spine Biologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Spine Biologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Spine Biologics Total Addressable Market (TAM)

6. Spine Biologics Market Segmentation

• 6.1. Global Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Allografts
• Bone Graft Substitute
• Platelet Rich Plasma
• Bone Marrow Aspirate Therapy
• 6.2. Global Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anterior Cervical Discectomy And Fusion (ACDF)
• Posterior Lumbar Interbody Fusion (PLIF)
• Transforaminal Lumbar Interbody Fusion (TLIF)
• Anterior Lumbar Interbody Fusion (ALIF)
• Lateral Lumbar Interbody Fusion (LLIF)
• Other Surgery Types
• 6.3. Global Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spinal Fusion
• Spinal Non-Union And Fracture Repair
• Degenerative Disc Disease Treatment
• Other Applications
• 6.4. Global Spine Biologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Spinal Surgery Centers
• Orthopedic Clinics
• Other End Users
• 6.5. Global Spine Biologics Market, Sub-Segmentation Of Bone Allografts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fresh Allografts
• Freeze-Dried Allografts
• 6.6. Global Spine Biologics Market, Sub-Segmentation Of Bone Graft Substitute, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Bone Grafts
• Demineralized Bone Matrix (DBM)
• Calcium Phosphate-Based Grafts
• Platelet Rich Plasma (PRP)
• 6.7. Global Spine Biologics Market, Sub-Segmentation Of Bone Marrow Aspirate Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Concentrated Bone Marrow Aspirate
• Bone Marrow Concentrates

7. Spine Biologics Market Regional And Country Analysis

• 7.1. Global Spine Biologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Spine Biologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Spine Biologics Market

• 8.1. Asia-Pacific Spine Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Spine Biologics Market

• 9.1. China Spine Biologics Market Overview
• 9.2. China Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Spine Biologics Market

• 10.1. India Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Spine Biologics Market

• 11.1. Japan Spine Biologics Market Overview
• 11.2. Japan Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Spine Biologics Market

• 12.1. Australia Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Spine Biologics Market

• 13.1. Indonesia Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Spine Biologics Market

• 14.1. South Korea Spine Biologics Market Overview
• 14.2. South Korea Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Spine Biologics Market

• 15.1. Western Europe Spine Biologics Market Overview
• 15.2. Western Europe Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Spine Biologics Market

• 16.1. UK Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Spine Biologics Market

• 17.1. Germany Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Spine Biologics Market

• 18.1. France Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Spine Biologics Market

• 19.1. Italy Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Spine Biologics Market

• 20.1. Spain Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Spine Biologics Market

• 21.1. Eastern Europe Spine Biologics Market Overview
• 21.2. Eastern Europe Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Spine Biologics Market

• 22.1. Russia Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Spine Biologics Market

• 23.1. North America Spine Biologics Market Overview
• 23.2. North America Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Spine Biologics Market

• 24.1. USA Spine Biologics Market Overview
• 24.2. USA Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Spine Biologics Market

• 25.1. Canada Spine Biologics Market Overview
• 25.2. Canada Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Spine Biologics Market

• 26.1. South America Spine Biologics Market Overview
• 26.2. South America Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Spine Biologics Market

• 27.1. Brazil Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Spine Biologics Market

• 28.1. Middle East Spine Biologics Market Overview
• 28.2. Middle East Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Spine Biologics Market

• 29.1. Africa Spine Biologics Market Overview
• 29.2. Africa Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Spine Biologics Market Competitive Landscape And Company Profiles

• 30.1. Spine Biologics Market Competitive Landscape
• 30.2. Spine Biologics Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Spine Biologics Market Other Major And Innovative Companies

• 31.1. Zimmer Biomet Holdings Inc.
• 31.2. Arthrex Inc.
• 31.3. Integra LifeSciences Corporation
• 31.4. Bone Biologics Corp.
• 31.5. InVivo Therapeutics Corp.
• 31.6. RTI Surgical Inc.
• 31.7. Paragon 28 Inc.
• 31.8. LifeNet Health Inc.
• 31.9. Xtant Medical Holdings Inc.
• 31.10. Kuros Biosciences A.G.
• 31.11. CoreLink LLC
• 31.12. Spinal Elements Inc.
• 31.13. Life Spine Inc.
• 31.14. Innovasis Inc.
• 31.15. Camber Spine Technologies LLC

32. Global Spine Biologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Spine Biologics Market

34. Recent Developments In The Spine Biologics Market

35. Spine Biologics Market High Potential Countries, Segments and Strategies

• 35.1 Spine Biologics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Spine Biologics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Spine Biologics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer